XNCR – xencor, inc. (US:NASDAQ)
Stock Stats
News
Xencor (NASDAQ:XNCR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Incyte announces EU approval of Xencor-partnered lymphoma therapy [Seeking Alpha]
Xencor (NASDAQ:XNCR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Xencor (NASDAQ:XNCR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Xencor (NASDAQ:XNCR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form 4 Xencor Inc For: Dec 19 Filed by: Desjarlais John R
Form 4 Xencor Inc For: Dec 19 Filed by: Dahiyat Bassil I
Form 144 Xencor Inc Filed by: Desjarlais John R
Form 144 Xencor Inc Filed by: Dahiyat Bassil I
Form SCHEDULE 13G/A Xencor Inc Filed by: VANGUARD GROUP INC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.